Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies

This article reviews the major clinical trial data that is the basis for the current chemotherapy regimens used as first- and second-line treatments for advanced pancreatic adenocarcinoma. We also review the current ongoing clinical trials, which include the use of agents targeting the oncogenic network signaling of K-Ras, agents targeting the extracellular matrix, and immune therapies.
Source: Therapeutic Advances in Medical Oncology - Category: Cancer & Oncology Authors: Tags: Reviews Source Type: research